- TRADE NAMES: Actigall (Watson); Adursall; Arsacol; Biliepar; Cholacid; Cholit-Ursan; Cholofalk; Coledos; Delursan; Desocol; Desoxil; Destolit (Norgine); Deurcil; Dexo; Estazor; Fraurs; Galmax; Lentorsil; Litanin; Litocure; Litoff; Litursol; Lyeton; Peptaron; Solutrat; UDC; UDC Hexal; Urdox (Wockhardt); Urso 250 (Aptalis); Urso Forte (Aptalis); Urso Heumann; Urso Vinas; Ursochol; Ursofal; Ursofalk; Ursoflor; Ursogal (Galen); Ursolac; Ursolism; Ursolvan; Urson; Ursoproge; Ursosan; Ursotan; USCA
- INDICATIONS: The dissolution of radiolucent (i.e. non-radio opaque) cholesterol gallstones in patients with a functioning gallbladder; primary biliary cirrhosis; biliary calculus; cholelithiasis
- SYNONYM: ursodeoxycholic acid; UDCA
- CLASS: Cholesterol antagonist, Urolithic
- HALF-LIFE: 100 hours
- CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
Aluminum based antacids, Aluminum hydroxide, Charcoal, Cholestyramine, Clofibrate, Colestimide, Colestipol, Cyclosporine, Dapsone, Estradiol, Estrogens, Nitrendipine, Oral Contraceptives, P4503A substrates
Please login to view the rest of this drug profile.
Page last updated 07/31/2023
